Skip to content

Clinical trials

Phase 3 Cardiovascular Diseases trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 3 Country / region: Czechia Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20071
20081
20092
20101
20113
20125
20132
20141
20162
20173
20182
20193
20221
20232
20242
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Terminated10
Recruiting5
Active, not recruiting4
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Eli Lilly and Company5
GlaxoSmithKline5
AstraZeneca3
Hoffmann-La Roche2
Ixaka Ltd2
Pfizer2
Sanofi2
United Therapeutics2
Alnylam Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases41
Diabetes Mellitus, Type 210
Myocardial Infarction9
Stroke9
Atherosclerosis8
Heart Diseases6
Hypertension6
Peripheral Arterial Disease5
Acute Coronary Syndrome4
Diabetes Mellitus4

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.